Simulations Plus Sets Date for First Quarter Fiscal Year 2021 Earnings Release and Conference Call

Rhea-AI Summary

Simulations Plus, Inc. (Nasdaq: SLP) will report its financial results for the first quarter of fiscal year 2021 after the market closes on January 11, 2021. A conference call will follow at 4:15 p.m. Eastern Time, inviting all interested parties to join by registering online or via phone. The call will also be available as a live webcast. Simulations Plus specializes in modeling and simulation software for drug discovery and development, with its technology used by several major pharmaceutical and biotechnology companies worldwide.

Positive

• Simulations Plus is a leader in modeling and simulation software, which is essential for drug discovery and development.
• The upcoming financial report could highlight growth in a critical sector of the pharmaceutical industry.

Negative

• None.

Simulations Plus, Inc. (Nasdaq: SLP), announced today that it will report its financial results for the first quarter of fiscal year 2021, ended November 30, 2020, after the close of the financial markets on Monday, January 11, 2021.

The Company will host a conference call on January 11, 2021, at 4:15 p.m. Eastern Time. All interested parties are invited to join the call by registering here or by calling 1-201-389-0879. Please join five to 10 minutes before the scheduled start time. The call will be simulcast live on the Internet, and the webcast will be available on the Investors page of the Simulations Plus website under Conference Calls & Presentations. A replay of the webcast will be available on the website approximately one hour following the call.

About Simulations Plus, Inc.

Simulations Plus, Inc., is a leading provider of modeling and simulation software and consulting services supporting drug discovery, development research, and regulatory submissions. With our subsidiaries, Cognigen, DILIsym Services, and Lixoft, we offer solutions which bridge machine learning, physiologically based pharmacokinetics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. Our technology is licensed and applied by major pharmaceutical, biotechnology, chemical, consumer goods companies and regulatory agencies worldwide. For more information, visit our website at www.simulations-plus.com.

Follow us on Twitter | LinkedIn | YouTube

View source version on businesswire.com: https://www.businesswire.com/news/home/20210104005212/en/

FAQ

When will Simulations Plus report its Q1 financial results?

Simulations Plus will report its Q1 financial results on January 11, 2021, after the market closes.

What time is the Simulations Plus conference call?

The conference call will take place at 4:15 p.m. Eastern Time on January 11, 2021.

How can I join the Simulations Plus conference call?

You can join the conference call by registering online or by calling 1-201-389-0879.

Where can I find the webcast of the Simulations Plus conference call?

The webcast will be available on the Investors page of the Simulations Plus website approximately one hour after the call.

What does Simulations Plus specialize in?

Simulations Plus specializes in modeling and simulation software for drug discovery and development, catering to pharmaceutical and biotechnology industries.